When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
AMGN - Mirati Is The Biotech To Watch As Second Half Catalyst Rapidly Approaches
Amgen Inc.
Mirati Therapeutics (MRTX) announced that it had formed a collaboration agreement with Novartis (NVS) to target patients with advanced solid tumors. This clinical combination is expected to go after a particular subset of the market dealing with solid tumors in a couple of cancer types. The heavy focus on a specific mutation target for cancer should lead to improved response rates. Mirati and Novartis are not alone in this space because they will have to go up against Amgen (AMGN) which is also exploring the very same space. Based